Interesting, could you describe one inefficiency that was exploited in the past? I could imagine buying/selling due to spreads between exchanges but is there another not as obvious example?
They are funded by several big pharma companies (from which they have learned a lot in terms of QSAR). One main point of the collaboration is the creation of production ready toolkits.